BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Presentation By Windber Research Institute CSO Highlights Application Of InforSense Limited KDE To Translational Medicine


10/19/2005 5:10:23 PM

LONDON--(BUSINESS WIRE)--May 10, 2005--InforSense Ltd, the leader in integrative analytics platforms, invites life science researchers and media to attend a presentation entitled "Redefining Translational Medicine for Drug Discovery" at the Drug Discovery & Technology Leaders Summit to be held in Montreux, Switzerland. This presentation by Prof. Michael Liebman, Chief Scientific Officer of the Windber Research Institute (WRI), will describe the ground-breaking workflow-based informatics platform for translational medicine being developed in collaboration with InforSense at WRI. Traditionally translational medicine has meant the translation of research at the bench to the bedside, i.e. into the clinic. In highlighting the Clinical Breast Care Project, jointly developed between WRI and its clinical collaborators, Prof. Liebman will demonstrate how their approach critically requires the need to also move from "bedside to bench". Enabling WRI's multi-disciplinary, clinical and molecular approach requires both an informatics infrastructure capable of integrating a wide variety of internal and external tools, algorithms, data types and data sources and also a rapid application development platform optimized for such a clinically driven 'top-down' approach for life science study. Both requirements will be met through the collaboration with InforSense and Prof. Liebman will describe the effort and the basis for this expanded view.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES